{"id":"https://openalex.org/W1970239019","doi":"https://doi.org/10.2174/0929867023369961","title":"Arylpiperazines with Affinity Toward a1-Adrenergic Receptors","display_name":"Arylpiperazines with Affinity Toward a1-Adrenergic Receptors","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W1970239019","doi":"https://doi.org/10.2174/0929867023369961","mag":"1970239019","pmid":"https://pubmed.ncbi.nlm.nih.gov/12052168"},"language":"en","primary_location":{"id":"doi:10.2174/0929867023369961","doi":"https://doi.org/10.2174/0929867023369961","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867023369961","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032250855","display_name":"Fabrizio Manetti","orcid":"https://orcid.org/0000-0002-9598-2339","observed_orcids":["https://orcid.org/0000-0002-9598-2339"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Manetti","raw_affiliation_strings":["Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi di Siena, Via Aldo Moro, Italy. manettif@unisi.it","Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi di Siena, Via Aldo Moro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi di Siena, Via Aldo Moro, Italy. manettif@unisi.it","institution_ids":["https://openalex.org/I102064193"]},{"raw_affiliation_string":"Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi di Siena, Via Aldo Moro, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041408400","display_name":"Federico Corelli","orcid":"https://orcid.org/0000-0002-5750-4504","observed_orcids":["https://orcid.org/0000-0002-5750-4504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Corelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003473752","display_name":"Giovannella Strappaghetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Strappaghetti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101466187","display_name":"Maurizio Botta","orcid":"https://orcid.org/0000-0003-0456-6995","observed_orcids":["https://orcid.org/0000-0003-0456-6995"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"M. Botta","raw_affiliation_strings":["Fabrizio Manetti,Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi diSiena, Via Aldo Moro, I-53100, Siena, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fabrizio Manetti,Dipartimento Farmaco Chimico Tecnologico, Universit\u00e0 degli Studi diSiena, Via Aldo Moro, I-53100, Siena, Italy.,Italy","institution_ids":["https://openalex.org/I102064193"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101466187"],"corresponding_institution_ids":["https://openalex.org/I102064193"],"apc_list":null,"apc_paid":null,"fwci":0.1912,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.41896782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"9","issue":"13","first_page":"1303","last_page":"1321"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.20839999616146088,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.10899999737739563,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/arylpiperazines","display_name":"arylpiperazines","score":0.984000027179718},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hit-compound-optimization","display_name":"hit compound optimization","score":0.6489999890327454},{"id":"https://openalex.org/keywords/alpha-1-adrenergic-agonists","display_name":"alpha-1 adrenergic agonists","score":0.6700000166893005},{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7990000247955322},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.9536003470420837},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6233195066452026},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5880160927772522},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.5459122657775879},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5083915591239929},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.47223803400993347},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.4226144850254059},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3667808771133423},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3576904535293579},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21599313616752625},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058668","descriptor_name":"Adrenergic alpha-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2174/0929867023369961","doi":"https://doi.org/10.2174/0929867023369961","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867023369961","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:12052168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12052168","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/22493","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/22493","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2948430538","doi":null,"is_oa":false,"landing_page_url":"https://usiena-air.unisi.it/handle/11365/22493","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.766700029373169,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2025491497","https://openalex.org/W2216717108","https://openalex.org/W2091352788","https://openalex.org/W2948430538","https://openalex.org/W2472044139","https://openalex.org/W2090495104","https://openalex.org/W2061683413","https://openalex.org/W2080484136","https://openalex.org/W2175282196","https://openalex.org/W2037890165"],"abstract_inverted_index":{"In":[0,72,100],"the":[1,9,33,62,93,114,130,135],"last":[2],"years,":[3],"alpha(1)":[4],"adrenoceptors":[5],"(alpha(1)-AR)":[6],"have":[7,22],"been":[8,80],"subject":[10],"of":[11,27,32,61,66,77,134,138,153],"intense":[12],"research,":[13],"in":[14],"part":[15],"because":[16,31],"receptor-binding":[17],"studies":[18],"and":[19,82,92,96,132],"molecular":[20],"biology":[21],"opened":[23],"up":[24],"new":[25,37,151],"aspects":[26],"understanding":[28],"but":[29],"also":[30],"potential":[34],"to":[35,122,149],"find":[36],"drugs":[38],"possibly":[39],"acting":[40],"toward":[41,125],"pathophysiological":[42],"processes":[43],"where":[44],"alpha(1)-AR":[45,91,126,158],"are":[46],"involved,":[47],"such":[48],"as":[49],"benign":[50],"prostatic":[51],"hyperplasia":[52],"(BPH)":[53],"or":[54],"hypertension.":[55],"At":[56],"present,":[57],"arylpiperazines":[58],"represent":[59],"one":[60],"most":[63],"studied":[64],"classes":[65],"molecules":[67],"with":[68,157],"affinity":[69,124,159],"at":[70,89,111],"alpha(1)-AR.":[71],"fact,":[73],"a":[74,103,107,118,139,144,150],"large":[75],"amount":[76],"work":[78],"has":[79],"done":[81],"reported,":[83],"describing":[84],"synthetic":[85],"procedures,":[86],"biological":[87],"evaluation":[88],"both":[90],"corresponding":[94],"subtypes,":[95],"structure-activity":[97],"relationships":[98],"(SARs).":[99],"this":[101],"paper,":[102],"review":[104],"based":[105],"on":[106,113],"literature":[108],"survey":[109],"aimed":[110],"focusing":[112],"structural":[115,136],"properties":[116],"that":[117],"compound":[119,141],"should":[120],"possess":[121],"show":[123],"is":[127,160],"presented.":[128],"Moreover,":[129],"identification":[131],"optimization":[133],"features":[137],"hit":[140],"derived":[142],"from":[143],"pharmacophore-based":[145],"database":[146],"search,":[147],"leading":[148],"class":[152],"arylpiperazinylalkyl":[154],"pyridazinone":[155],"derivatives":[156],"reported.":[161]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}